LFG
SRNE

Larson Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Larson Financial Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,825
Closed -$14K – 1614
2022
Q4 		$14K Hold
15,825
– – ﹤0.01% 773
2022
Q3 		$25K Buy
15,825
+5,000
+46% +$11.3K ﹤0.01% 582
2022
Q2 		$22K Hold
10,825
– – ﹤0.01% 532
2022
Q1 		$25K Buy
10,825
+6,040
+126% +$18.8K ﹤0.01% 494
2021
Q4 		$22K Hold
4,785
– – ﹤0.01% 524
2021
Q3 		$37K Buy
4,785
+898
+23% +$7.62K 0.01% 353
2021
Q2 		$38K Buy
+3,887
New +$31K 0.01% 323

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Larson Financial Group's SRNE Position: Q1 2023 in Review

Larson Financial Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 15,825 shares — an estimated $14K sold.

Larson Financial Group first reported a position in SRNE in Q2 2021 and held it in 7 quarters. The position peaked at $38K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Larson Financial Group reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Larson Financial Group sold 15,825 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $14K.
  • Larson Financial Group first reported a position in Sorrento Therapeutics, Inc. in Q2 2021 and held it in 7 quarters.
  • Larson Financial Group's Sorrento Therapeutics, Inc. position peaked at $38K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Larson Financial Group's 13F filing for Q1 2023, filed 4 May 2023.